Pfizer, Inc.

National Advisory Committee on Immunization issues guidance on 15-valent and 20-valent conjugate pneumococcal vaccines for preventing invasive pneumococcal disease.

This new combo product will be used to manage heavy menstrual bleeding associated with uterine fibroids, and moderate to severe pain associated with endometriosis.

Medication could be game-changer for patients as it combines replacement hormones and relugolix in a single tablet taken once daily.

The pharmaceutical company said it will focus instead on a once-daily version of the pill, danuglipron, instead of starting a late-stage study of the other version.

The Healthcare Divide takes a hard look at healthcare inequities relating to race.

What's available to help patients with this chronic inflammatory skin condition?

Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023.

The Food and Drug Administration decision opens the newest shots from Moderna and Pfizer and its partner BioNTech to most Americans even if they’ve never had a coronavirus vaccination.